Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Baverel

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Biochimie|December 4, 2003
Carbon 13 NMR spectroscopy: a powerful tool for studying renal metabolismG Baverel, A Conjard, M-F Chauvin, et al.
Clinical Pharmacology and Therapeutics|December 16, 2017
Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial CarcinomaYanan Zheng, Rajesh Narwal, ChaoYu Jin, et al.
Clinical Pharmacology and Therapeutics|December 16, 2017
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease StatusPaul G Baverel, Vincent F S Dubois, Chao Yu Jin, et al.
Cell Biology and Toxicology|December 1, 1996
Advantages and limitations of the use of isolated kidney tubules in pharmacotoxicologyM F Chauvin, C Bolon, A Conjard, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Biochimie|December 4, 2003
Carbon 13 NMR spectroscopy: a powerful tool for studying renal metabolismG Baverel, A Conjard, M-F Chauvin, et al.
Clinical Pharmacology and Therapeutics|December 16, 2017
Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial CarcinomaYanan Zheng, Rajesh Narwal, ChaoYu Jin, et al.
Clinical Pharmacology and Therapeutics|December 16, 2017
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease StatusPaul G Baverel, Vincent F S Dubois, Chao Yu Jin, et al.
Cell Biology and Toxicology|December 1, 1996
Advantages and limitations of the use of isolated kidney tubules in pharmacotoxicologyM F Chauvin, C Bolon, A Conjard, et al.
Pageof 8